These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8459893)

  • 21. Evaluation of Dalbavancin in Vancomycin Allergic Patients: A Case Series.
    Jones BM; Freeman KJ; Cleveland KO; Bland CM
    Clin Ther; 2022 Dec; 44(12):e59-e63. PubMed ID: 36464517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
    Hung YP; Lee NY; Chang CM; Lee HC; Wu CJ; Chen PL; Lee CC; Chung CH; Ko WC
    Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6.
    Tamagawa-Mineoka R; Katoh N; Nara T; Nishimura Y; Yamamoto S; Kishimoto S
    Int J Dermatol; 2007 Jun; 46(6):654-5. PubMed ID: 17550572
    [No Abstract]   [Full Text] [Related]  

  • 24. Teicoplanin hypersensitivity syndrome.
    Lye D; Athan E; O'Brien D
    Int J Antimicrob Agents; 2007 Apr; 29(4):476-8. PubMed ID: 17298875
    [No Abstract]   [Full Text] [Related]  

  • 25. [Glycopeptide-induced cutaneous adverse reaction: results of an immunoallergic investigation in eight patients].
    Perrin-Lamarre A; Petitpain N; Trechot P; Cuny JF; Schmutz JL; Barbaud A
    Ann Dermatol Venereol; 2010 Feb; 137(2):101-5. PubMed ID: 20171430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
    Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
    J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graded Dalbavancin Challenge in a Patient With Severe Vancomycin Hypersensitivity Reaction.
    Ishizuka KT; Tran TK; Ayars AG; Chau AS; Chan JD
    Clin Infect Dis; 2020 Mar; 70(6):1230-1232. PubMed ID: 31300814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retrospective analysis of the Gram-positive bacteria-infected cases in the Department of Hematology].
    Jing Y; Bo J; Zhao Y; Li HH; Wang SH; Huang WR; Wang QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1291-5. PubMed ID: 24156452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immuno-allergic erythroderma caused by vancomycin].
    Rimailho A; Riou B; Teboul JL; Richard C; Auzepy P
    Presse Med; 1984 Mar; 13(9):567. PubMed ID: 6230660
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Shen WC; Chiang YC; Chen HY; Chen TH; Yu FL; Tang CH; Sue YM
    Nephrology (Carlton); 2011 Nov; 16(8):697-703. PubMed ID: 21707841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glycopeptides (vancomycin, teicoplanin)].
    Furuta I; Kitahashi T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():423-6. PubMed ID: 15658354
    [No Abstract]   [Full Text] [Related]  

  • 34. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
    Hahn-Ast C; Glasmacher A; Arns A; Mühling A; Orlopp K; Marklein G; Von Lilienfeld-Toal M
    Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A closer look at vancomycin, teicoplanin, and antimicrobial resistance.
    Zeckel ML
    J Chemother; 1997 Oct; 9(5):311-31; discussion 332-5. PubMed ID: 9373787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
    Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
    Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teicoplanin.
    Salaria M
    Indian Pediatr; 2001 Apr; 38(4):372-5. PubMed ID: 11313506
    [No Abstract]   [Full Text] [Related]  

  • 38. [Erythroderma induced by teicoplanin].
    Paul C; Janier M; Carlet J; Tamion F; Carlotti A; Fichelle JM; Daniel F
    Ann Dermatol Venereol; 1992; 119(9):667-9. PubMed ID: 1285594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vancomycin and teicoplanin: differential aspects].
    Cobo J
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):600-10. PubMed ID: 8808477
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
    Huang JH; Hsu RB
    Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.